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Abstract 
Short communication on CADM4, with data on 
DNA/RNA, on the protein encoded and where the 
gene is implicated. 
Identity 
Other names: IGSF4C, NECL4, Necl-4, TSLL2, 
synCAM4 
HGNC (Hugo): CADM4 
Location: 19q13.31 
DNA/RNA 
Description 
DNA contains 17470 bases composed of 9 coding 
exons. 
Transcription 
2176 bp mRNA transcribed in telomeric to 
centromeric orientation; 1164 bp open reading 
frame. 
Protein 
 
Description 
CADM4 encodes an immunoglobulin (Ig) 
superfamily cell adhesion molecule containing three 
Ig-like loops in their extracellular domain, a single 
transmembrane domain, and a short cytoplasmic 
domain with a protein 4.1-binding motif and a PDZ 
II-binding motif.  
The cytoplasmic domain is bound to the actin 
cytoskeleton through protein 4.1 such as 
4.1B/DAL-1. CADM4 protein is 388 amino acids 
long and its molecular weight ranges from 
approximately 50 to 55 kDa dependent on N-
glycosylation in the extracellular domain 
(deglycosylated form: 45 kDa). 
Expression 
Brain, peripheral nerve, lung, large and small 
intestines, kidney, bladder, and prostate.  
Loss of expression is frequently observed in various 
cancers. 
Localisation 
Cell membrane (type I transmembrane protein); 
Cell-cell contact site in epithelial tissues. 
Function 
CADM4 forms homophilic cis-dimers on the cell 
surface and mediates Ca2+-independent cell-cell 
adhesion in a heterophilic manner with 
CADM2/Necl-3 or CADM3/Necl-1. CADM4 
associates with 4.1B in the kidney. 
Homology 
Pan troglodytes - CADM4; Canis lupus familiaris - 
CADM4; Bos taurus - CADM4; Mus musculus - 
Cadm4; Rattus norvegicus - Cadm4; Danio rerio - 
cadm4. 
Mutations 
Note 
No reports. 
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Implicated in 
Prostate cancer 
Oncogenesis 
CADM4 protein is lost or markedly reduced in nine 
of nine primary prostate cancers and two of four 
prostate cancer cell lines, PPC-1 and Du145, in 
comparison with that in normal human prostate. 
The tumorigenicity of PPC-1 was strongly 
suppressed by restoration of CADM4 expression 
without inducing significant cell death or growth 
inhibition in vitro, suggesting that the inactivation 
of CADM4 would be involved not in the direct cell 
growth but in the aberrant cell-cell contact in the 
prostate carcinogenesis. 
Renal clear cell carcinoma 
Prognosis 
The expression of CADM4 is lost or markedly 
reduced in 70% of primary renal clear cell 
carcinoma (RCCC), where loss of CADM4 in 
RCCC correlates with vascular infiltration. 
Oncogenesis 
CADM4 and its binding partner 4.1B are 
specifically expressed along the cell membrane in 
the proximal convoluted tubules, from which 
RCCC is derived.  
Approximately 80% of primary RCCC showed loss 
or marked reduction of either CADM4 or 4.1B, 
indicating that disruption of the CADM4-4.1B 
cascade is one of the most frequent events in 
RCCC.  
The CADM4 gene in human renal cell carcinoma 
cell 786-O was inactivated by promoter 
methylation, while restoration of CADM4 
expression strongly suppressed subcutaneous tumor 
formation in nude mice by 786-O cells. 
Colorectal adenocarcinoma 
Prognosis 
CADM4 expression is lost or reduced in 23% or 
36% of colorectal adenocarcinoma, respectively. 
Loss or down-regulation of CADM4 is correlated 
with larger tumor size, mucinous tumor type, 
poorer differentiation, lymph node metastasis, and 
higher Dukes stage. 
Oncogenesis 
Loss or down-regulation of CADM4 expression 
was positively correlated with low E-cadherin 
expression and high Ki-67 expression in colorectal 
adenocarcinoma.  
The restoration of CADM4 expression in LS174T 
human colon cancer cells suppressed cell growth, 
colony formation, motility, and tumorigenic 
capacity. These results suggest that CADM4 may 
be involved in the maintenance of epithelial 
structure and suppression of tumor growth. 
Breast cancer (ductal carcinoma) 
Prognosis 
CADM4 expression was higher in ductal carcinoma 
in situ cases (82%) than invasive ductal 
adenocarcinoma cases (68%). Loss or reduced 
expression of CADM4 was significantly correlated 
with higher histological grade, overexpression of 
ErbB2 and absence of estrogen and/or progesterone 
receptors. CADM4 expression is associated with 
longer disease-free survival in stages I and II 
invasive ductal adenocarcinoma cases. 
Oncogenesis 
Loss or reduced expression of CADM4 may play an 
important role in breast cancer invasiveness. 
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